Recent studies have focused on the potential application of TRAIL in autoimmune diseases, anti-cancer therapy [4], [5], and Type I diabetes [17]; although, the role of TRAIL in the immune system and its functional mechanisms are still controversial [18]. The gene discussed is TNFSF10; the disease is type 1 diabetes mellitus.